US Map / Massachusetts
State MA

Clinical Trials in Massachusetts

Recruiting clinical trials with at least one study location in Massachusetts. Data updated daily from ClinicalTrials.gov.

Total Trials
482
Recruiting Now
482
← Back to US Map
Top Conditions in Massachusetts
Breast Cancer (11)Multiple Myeloma (6)Obesity (6)Chronic Lymphocytic Leukemia (6)Small Lymphocytic Lymphoma (6)Prostate Cancer (6)Stroke (5)Metastatic Breast Cancer (5)Asthma (5)Major Depressive Disorder (5)Hypertension (5)Advanced Solid Tumor (5)

Frequently Asked Questions — Clinical Trials in Massachusetts

How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 482 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 482. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Massachusetts

NCT05533697 Phase 1, Phase 2
Recruiting
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint ...
Condition
Advanced Solid Tumors
Enrollment
361 pts
Location
United States, Australia, Spain
Sponsor
ModernaTX, Inc.
View Trial →
NCT05692180 Phase 3
Recruiting
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim...
Condition
Asthma
Enrollment
200 pts
Location
United States, Argentina, Canada
Sponsor
AstraZeneca
View Trial →
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
View Trial →
NCT06376162 Phase 1
Recruiting
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractor...
Condition
Relapsed/Refractory KMT2A-r Acute Leukemia
Enrollment
20 pts
Location
United States, Austria, Canada
Sponsor
PedAL BCU, LLC
View Trial →
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
View Trial →
NCT04998396 Phase 1, Phase 2
Recruiting
A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Cli...
Condition
Canavan Disease
Enrollment
26 pts
Location
United States
Sponsor
Aspa Therapeutics
View Trial →
NCT06958796 Phase 4
Recruiting
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Condition
Cytomegalovirus
Enrollment
80 pts
Location
United States
Sponsor
Camille N. Kotton, MD
View Trial →
NCT06165341 Phase 3
Recruiting
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alp...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
50 pts
Location
United States, Austria, Belgium
Sponsor
Takeda
View Trial →
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
View Trial →
NCT07015905 Phase 3
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee ...
Condition
Venous Thromboembolism (VTE)
Enrollment
2,000 pts
Location
United States, Bulgaria, Hungary
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
View Trial →
NCT05647122 Phase 1
Recruiting
First in Human Study of AZD9592 in Solid Tumors
Condition
Advanced Solid Tumours
Enrollment
403 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06121661 Phase 1
Recruiting
APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System
Condition
Wounds and Injuries
Enrollment
20 pts
Location
United States
Sponsor
Andrew Tomas Reisner
View Trial →
NCT04424979 N/A
Recruiting
Feasibility Tests for Various Prism Configurations for Visual Field Loss
Condition
Hemianopia, Homonymous
Enrollment
20 pts
Location
United States
Sponsor
Massachusetts Eye and Ear Infi
View Trial →
NCT05662423 N/A
Recruiting
Preventing Childbirth-Related PTSD With Expressive Writing
Condition
PTSD (Childbirth-Related)
Enrollment
136 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT05836259 Phase 1, Phase 2
Recruiting
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability...
Condition
Hypertrophic Cardiomyopathy
Enrollment
30 pts
Location
United States
Sponsor
Tenaya Therapeutics
View Trial →
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT06976203 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Imp...
Condition
Alzheimer's Disease
Enrollment
586 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04485286 Phase 2
Recruiting
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue ...
Condition
Lung Cancer
Enrollment
72 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05754073 Phase 2
Recruiting
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
Condition
Autism Spectrum Disorder
Enrollment
96 pts
Location
United States
Sponsor
Elizabeth Austen Lawson
View Trial →
NCT06647979 Phase 1
Recruiting
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopat...
Condition
Sickle Cell Disease
Enrollment
10 pts
Location
United States
Sponsor
Daniel Bauer
View Trial →
NCT07052942 Phase 4
Recruiting
Individualizing Treatment for Asthma in Primary Care (Full Study)
Condition
Asthma
Enrollment
3,200 pts
Location
United States
Sponsor
DARTNet Institute
View Trial →
NCT06457503 Phase 4
Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Particip...
Condition
Nasopharyngeal Cancer Recurrent
Enrollment
100 pts
Location
United States, Canada
Sponsor
Coherus Oncology, Inc.
View Trial →
Page 3 of 20 — 482 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology